Question to the Department of Health and Social Care:

To ask the Secretary of State for Health, pursuant to the Answer of 9 February 2016 to Question 25939, what proportion of the income from estimated Pharmaceutical Price Regulation Scheme payments for 2016-17 will be brought forward from estimated payments due in (a) 2017-18 and (b) 2018-19.

The Government announced in December 2015 that the Pharmaceutical Price Regulation Scheme (PPRS) payment percentage for the 2016 calendar year is 7.80%. This represents an increase of 2.64 percentage points as a result of the addendum to the PPRS agreed with the Association of the British Pharmaceutical Industry and published alongside the 2016 payment percentage. The income brought forward to 2016 as a result of this agreement will depend on a number of factors, including total branded medicine sales to the National Health Service over the course of the year.